0000899243-22-011033.txt : 20220315
0000899243-22-011033.hdr.sgml : 20220315
20220315152310
ACCESSION NUMBER: 0000899243-22-011033
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220311
FILED AS OF DATE: 20220315
DATE AS OF CHANGE: 20220315
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vellanki Avanish
CENTRAL INDEX KEY: 0001856682
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40356
FILM NUMBER: 22740717
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Rain Therapeutics Inc.
CENTRAL INDEX KEY: 0001724979
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 821130967
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
BUSINESS PHONE: (510) 953-5559
MAIL ADDRESS:
STREET 1: 8000 JARVIS AVENUE
STREET 2: SUITE 204
CITY: NEWARK
STATE: CA
ZIP: 94560
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-03-11
0
0001724979
Rain Therapeutics Inc.
RAIN
0001856682
Vellanki Avanish
C/O RAIN THERAPEUTICS INC.
8000 JARVIS AVENUE, SUITE 204
NEWARK
CA
94560
1
1
0
0
President and CEO
Common Stock
2022-03-11
4
M
0
14468
4.00
A
2837009
D
Common Stock
138901
I
By Trust
Stock Option (Right to Buy)
4.00
2022-03-11
4
M
0
14468
0.00
D
2030-11-12
Common Stock
14468
31832
D
This option represents a right to purchase a total of 46,300 shares of the Issuer's common stock, which vests in equal monthly installments through November 13, 2024, subject to the Reporting Person's continued service to the Issuer.
/s/ Nelson Cabatuan, Attorney-in-fact for Avanish Vellanki
2022-03-15